In particular, Positron Emission Tomography/Computed Tomography (PET/CT) with Prostate-Specific Membrane Antigen (PSMA) radiolabeled with 18F or 68Ga has significantly affected the management of patients with PCa, mainly in cases of biochemical recurrence of disease, with a substantial impact on the therapeutic management [12]. Here, FOLH1 is linked to posterior cortical atrophy.